Posted by Michael Wonder on 21 Dec 2022
Aequus announces Health Canada Notice of Compliance for Zimed Preservative Free (bimatoprost 0.03%)
20 December 2022 - Aequus Pharmaceuticals is pleased to announce that Health Canada has approved Zimed PF (bimatoprost 0.03%) for the reduction of elevated intra-ocular pressure in patients with open-angle glaucoma or ocular hypertension.
Zimed PF is the first prostaglandin analogue that is preservative free and offered in an easy to use multi-dose bottle in Canada.
